MedVi vs Peter MD: Compare GLP-1 Programs & Pricing
Side-by-side MedVi and Peter MD: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
MedVi and Peter MD are telehealth providers that support access to GLP-1–class medications for weight-management under clinician supervision. This guide compares pricing transparency, clinical workflows, medication quality, and patient experience so you can make an informed decision. All information reflects published program details and standard telehealth practices; it is not a substitute for medical advice.
MedVi vs Peter MD: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| MedVi | $179.00 | $279.00 | $120 off first month (Code: none provided) | No membership required |
| Peter MD | Not listed | Not listed | No public promo listed | Not specified |
MedVi vs Peter MD: Medical Process & Accessibility
MedVi emphasizes rapid telehealth intake and clinician review: patients complete an intake, medical history is evaluated by a licensed clinician, and prescriptions may be issued when clinically appropriate. Peter MD also uses telehealth workflows and reports follow-up visits and dose adjustments as part of ongoing care. Both providers operate within U.S. telemedicine laws and require clinician assessment prior to prescribing GLP-1 therapies.
MedVi vs Peter MD: Pricing Comparison
MedVi lists semaglutide starting at $179.00 and tirzepatide starting at $279.00. Peter MD does not publish clear starting prices on the public page we referenced, so total cost may vary and could include consultation or pharmacy fulfillment fees. When one provider publishes a lower starting fee, that price is highlighted for quick comparison.
If price transparency is important, MedVi provides explicit starting points and a promotional discount of $120 off the first month. Peter MD users should contact the provider directly or follow the official link to confirm exact costs, shipping, and any membership or subscription fees before enrolling.
MedVi vs Peter MD: Clinical Oversight & Support
Both services route patient evaluations through licensed medical professionals. Typical care includes medical history review, safety screening for contraindications, and scheduled follow-ups to assess tolerability and dose adjustments. Telehealth providers must adhere to state licensing rules and standard prescribing guidelines; they cannot legally prescribe without an appropriate clinical evaluation.
MedVi vs Peter MD: Medication Quality & Safety
Telehealth programs may provide branded FDA-approved medications or compounded alternatives dispensed by U.S. pharmacies. Important compliance notes: only FDA-approved brand products (for example, Wegovy® or Mounjaro®) have undergone the full FDA approval process for labeled indications. Compounded products are legal when prescribed by a licensed clinician but are not identical to branded formulations. Always discuss risks, benefits, and FDA status with your clinician prior to starting any medication.
MedVi vs Peter MD: Customer Experience
User reports typically emphasize affordability and fast onboarding for MedVi, while Peter MD is often recognized for detailed clinical follow-up and patient communication. Shipping times, pharmacy partners, and customer support responsiveness can affect the overall experience; check recent reviews and ask questions about pharmacy sourcing and return policies during your consultation.
MedVi vs Peter MD: Final Verdict
Choose MedVi if transparent starting prices and a low-cost entry point are priorities. Choose Peter MD if you prefer providers that emphasize structured follow-up and personalized dose adjustments (note: verify pricing with Peter MD directly). Both operate under telehealth clinical protocols and require clinician assessment before medication is prescribed.
Join MedVi
Get Started with Peter MD
Disclaimer
This article is for informational purposes only and does not constitute medical advice. Pricing, promotions, and program features can change; contact each provider for current details. Always consult a licensed clinician to determine whether GLP-1 therapies are safe and appropriate for you. ExploreProviders.com may receive affiliate commissions at no extra cost to you.